All posts by imreal

The First, in Scottsdale, Arizona, Offers CE/CME to Address the Public Health Crisis of Opioid Abuse


News Image

…my new PAINWeekEnd talks on risk mitigation and documentation are designed to help you demonstrate meaningful risk mitigation processes and document individualized patient care plans. The time you invest…will help preserve patient access to quality pain care!

PAINWeekEnd on March 21 and 22 at the Hilton Scottsdale Resort, 6333 North Scottsdale Road, in Arizona, will be a timely and relevant 2-day program providing busy clinicians and allied healthcare practitioners with 12.0 hours of relevant, practical instruction in the management of chronic pain.

In 2020, paper prescriptions for certain painkillers have been banned in Arizona. For schedule II controlled opioids, healthcare professionals are required to submit prescriptions electronically to pharmacists, to crack down on forged prescriptions. This requirement is part of the Arizona Opioid Epidemic Act signed into law by Governor Doug Ducey in 2018.

At PAINWeekEnd Scottsdale, senior faculty member Jen Bolen will be among the presenters. Her presentations are called: Drugs, Documentation, and DEA: Improving your Charting of Prescribing Rationale in 2020 and Beyond and Through the Lens of Experts: Meaningful Risk Mitigation and Patient Education. Attorney Bolen commented, “The DEA and licensing boards continue to aggressively pursue cases against healthcare providers for inappropriate opioid prescribing. Bad outcomes in these cases are typically the result of overly generalized risk mitigation processes and poor documentation. While you may not be able to stop an investigation or lawsuit, my new PAINWeekEnd 2020 talks on risk mitigation and documentation are designed to help you demonstrate meaningful risk mitigation processes and document individualized patient care plans. The time you invest in yourself and your practice skills will be well spent, and will help preserve patient access to quality pain care! See you soon!”

Other courses include Pain Pathways Made Simple; Nonopioid Analgesics, Adjuvants, and Antidepressants; Interventional Pain Management: Opioid-Sparing Technologies; Clinical Pearls: Unraveling the Secrets of Imaging Studies; Rational Polypharmacy; Spinal Stenosis: Epidemiology, Pathophysiology, and Treatment; After the Goldrush: Testing Medical Cannabis and CBD in Chronic Pain Patients; What’s All the “GABA” About? Pregabalin and Gabapentin Abuse; and Everybody’s Greasing Up, But Should You Rub It In? A Review of Topical Analgesics and Available Evidence in Clinical Trials.

Commercially supported activities—addressing a range of product, disease state, and medical information topics—will also be presented.

For more information about this or other regional conferences, and to register for $199, go to the PAINWeekEnd website. BONUS: PAINWeekEnd registrants may register for the 2020 PAINWeek National Conference, September 8-12, in Las Vegas, for $200 off the regular online published price.

Global Education Group:

Global Education Group focuses on producing partnership-based CME for healthcare practitioners. The Global team works with a select group of medical education companies, associations, academic institutions and healthcare facilities to develop and accredit live healthcare conferences and workshops as well as online activities. With each partnership or joint providership, Global brings accreditation expertise, project management excellence and grant funding intelligence. Based in Littleton, Colo., Global has accreditation with commendation from the ACCME. Global also holds accreditations to offer continuing education for nurses, nurse practitioners, pharmacists, dietitians, dentists and psychologists. Global is a division of Ultimate Medical Academy.

Share article on social media or email:

Polyverse Lands $8m in New Funding to Accelerate Security Push into Government, Enterprise and IoT


Photo of Alex Gounares

CEO Alex Gounares

Polyverse Corporation received $8m in new funding to accelerate the adoption of its groundbreaking cybersecurity technology among government agencies and solution providers. The new funding was led by existing investors and Japanese security giant Soliton Systems KK.

“We are pleased to extend our partnership with Polyverse through our investment. Polyverse’s security breakthroughs are enabling us to create radically improved products for our customers,” said Nobuo Kamata, President of Soliton.

Founded in 2015 by bringing together top engineering talent from Microsoft, Amazon, Google and the academic world, Polyverse develops leading-edge cybersecurity technology – including “Polymorphing for Linux,” that protects servers against memory-based exploits by stopping zero-day, code-execution, overflow and memory-based attacks. Polyverse technology is widely deployed by government and security-conscious organizations, and is also embedded in IoT devices and connected hardware such as healthcare devices. CNBC recently named Polyverse one of the world’s top 100 start-ups.

Polymorphing hardens open source Linux distributions by scrambling the source code without affecting its operation, functionality or performance. This makes each version of the OS unique and prevents attackers from applying their knowledge of OS weaknesses to a company’s systems, rendering their attacks useless.

Polyverse Polymorphed Linux is currently running on millions of servers. Polyverse technology has been validated by the U.S. Department of Defense to mitigate against zero-day memory exploits like WannaCry and Spectre, and the attacks on companies such as Equifax.

“Our mission is to solve the cybersecurity problem once and for all. The only way that will happen is if we take a different approach,” said Alex Gounares, CEO, Polyverse. “By building diversity and uniqueness across multiple system dimensions, Polymorphing increases the complexity and cost for attackers and stops attacks before they start.”

Expanded Leadership Team Broadens Government and Enterprise Reach

The new funding will be used to accelerate investment in expanding polymorphic technologies and adding new geographies and new capabilities such as polymorphic script engines and polymorphic build farms, for DevSecOps.

The company also added key new members to its team, including:


  • Mark “Zibo” Joseph Zbikowski, a former Microsoft Architect and an early computer hacker. He was the designer of the MS-DOS executable file format, and the headers of that file format start with his initials: the ASCII characters “MZ” (0x4D, 0x5A).
  • Phillip Cockrell, Vice President, Enterprise Sales, former Vice President of Global Alliances at SUSE, the first provider of an Enterprise Linux distribution. Cockrell led strategic sales relationships with SUSE’s top partners, including Amazon Web Services, Dell, Fujitsu, HPE, IBM and Microsoft Azure, and led strategy and execution for SUSE’s global embedded program and platform-as-a-service solutions.
  • Joanne Harris, Chief Marketing Officer, and former Global Vice President of Marketing at SUSE. Harris held responsibility for marketing strategy and planning across all marketing functions world-wide. Harris previously led EMEA Strategic Alliances and Partner Marketing for Veritas Software.


Polyverse has expanded its employee base by 50% over the past year. The new funding will enable Polyverse to continue expansion in North America and Japan, and enter strategic new markets in 2020, including the UK, and Singapore.

About Polyverse:

Polyverse Corporation is a cybersecurity company that uses its revolutionary Polymorphing technology to defend global enterprises and governments against the most devastating zero-day cyberattacks. Its technology has been validated by the U.S. Department of Defense to mitigate against zero-day memory exploits. Polyverse’s turnkey solution installs in minutes and works with existing systems without changing performance or IT processes. Founded in 2015, Polyverse is led by founder and CEO Alex Gounares. In November 2019, CNBC named Polyverse as one of the Top 100 Startups in the World. Visit our website, read our blog, and follow us on Twitter @polyverse_corp. For any questions please contact Joanne Harris on +1 855 765 9837 or jharris@polyverse.com.

Share article on social media or email:

Inventory Optimization Solutions (IOS) Announces Advanced Urology Institute (AUI) has Received Q4 2019 Best Practice Award


“I wouldn’t want to do my job without IOS – their team is truly part of my business. They help solve problems and when I need an enhancement to the system, I pass it to IOS through my account manager. We’ve been able to suggest several key new features that are now part of Envi.” – Sonya DeMarco

Inventory Optimization Solutions (IOS) is pleased to announce Advanced Urology Institute (AUI) has received the Q4 2019 Best Practice Award. AUI has demonstrated outstanding capabilities in using the Envi® solution to reduce costs and manage supply chain across a diverse group of clinics and surgery centers. IOS continually identifies and shares best practices from customers to help educate the healthcare community on supply chain automation. Each quarter, IOS recognizes an organization demonstrating supply chain excellence.

About the Organization

AUI is a rapidly expanding urology group that includes clinics and ambulatory surgery centers in Florida and Georgia. With a mission to advance patient-centered urologic care, AUI was developed as a single-specialty physician-led organization to respond to the mounting changes in healthcare. With challenges faced by solo and small group practices, AUI has succeeded by combining geographically disparate urology groups and helping them function efficiently and effectively, while delivering the highest quality medical care to patients.

Setting Goals for Supply Chain

Sonya DeMarco, Director of Supply Chain Management, is responsible for cost control, inventory control and contracting at this rapidly growing organization. Five years ago, Sonya and the team selected Envi from IOS to manage their supply chain needs, with specific goals that included:

1)    Fully automated 3-way match

2)    Multi location capabilities

3)    A solution that can address growing needs, with the support needed to enable their expansion

4)    Reporting tools to create visibility at both the individual organization and enterprise level

Best Practice Improvements

“A day in the life of an Envi user at AUI involves an office manager or nurse, who logs into Envi and creates a requisition from their ‘favorites list,’ which is now a feature of the Envi solution that IOS developed based on our need for a user-specific template,” said DeMarco. “The user submits a requisition, which comes to my department for approval and transmit. When we became AUI, purchasing was the first thing we centralized. We stopped significant expense bleeding and today, can immediately identify any instances where we’re overcharged, charged for extraneous fees like expedited shipping, shipping and handling fees, or any other add-on charges. We’ve eliminated 100% of these charges and in the first year, saved nearly $100,000.”

As multiple locations came together to form AUI, and the initial 5 year plan called for even greater growth, it became clear that location capabilities varied, especially when it came to 3-way price matching. DeMarco continued, “Some systems could do two parts of the 3-way match but none could exchange data with our AP system, so we had to do manual matching. We knew that wouldn’t be sustainable, and with growth, we had to have 3-way match without manual intervention. We do this with Envi. We ship directly to facilities, where they receive and put away supplies. The corporate team ‘oversees’ the receiving process to make sure we have all parts of the 3-way match enabled. If that doesn’t happen, invoices can’t get paid, which is unacceptable, because we’re committed to good partnerships with our vendors.”

“I wouldn’t want to do my job without IOS – their team is truly part of my business,” concluded DeMarco. “They help solve problems and when I need an enhancement to the system, I pass it to IOS through my account manager. We’ve been able to suggest several key new features that are now part of Envi. Our physicians want to deliver the care that’s right for our patients, and with Envi, we maintain our patient focus and deliver the cost-effective care they need.”

Best Practice-based Processes

The team at AUI has demonstrated exceptional use of the Envi solution, and is recognized for their success in:

1.    Controlling purchasing with customized “favorites lists” for users

2.    Consolidating product formulary used at over 40 locations in six facilities

3.    Managing contracts and accurate contract pricing across enterprise

4.    Maintaining 3-way price matching to ensure correct prices charged and invoices seamlessly paid to vendor partners

5.    Using Envi reporting capabilities for both enterprise and facility level management

A Best Practice Based Community of Healthcare Organizations

IOS works with more than 5,000 healthcare facilities throughout the United States. As a result of this large footprint and broad range of users, IOS is able to identify, document and share best practices that are designed to help healthcare organizations improve their supply chain processes and overall results.

“We’re so pleased to partner with organizations like Advanced Urology Institute,” said Steve Britt, President, IOS. “Through our ongoing working relationship, we not only hear what’s working but also, what new features could enhance our user’s experiences. The team at AUI has helped us develop several key features that are now part of Envi, which today are being used in provider organizations throughout the U.S. It’s this type of collaboration – this partnership spirit – that enables our team to truly help Envi users solve their supply chain challenges.”

# # #

About Inventory Optimization Solutions (IOS)

Inventory Optimization Solutions (IOS) provides healthcare organizations with powerful, cost-effective, uniquely modular, and easy-to-use web-based supply chain solutions that offer the flexibility to support facilities throughout the continuum of care. IOS operates with a commitment to delivering world-class customer service, guiding customers to a better supply chain, providing high-touch support, industry best-practices, deep healthcare expertise and continuously evolving solutions that help them succeed. The goal of IOS is to ensure customers have more time each day for their most important role: caring for patients. For more information, visit http://www.ioscorp.com.

Share article on social media or email:

New Report on Addressing the Loneliness Crisis Through the Power of Pets


News Image

Mars Petcare and the Human Animal Bond Research Institute (HABRI), with support from a broad consortium of partners, today released a report that offers a roadmap for advancing research and best practices that address how human-animal interaction can serve as an important solution to the growing epidemic of loneliness and social isolation.

“There is increasing evidence that pets can play an important role in helping people feel less lonely and more socially connected,” said Steven Feldman, Executive Director, HABRI. “Together with the leadership of Mars Petcare and a group of other experts and stakeholders, HABRI will work to address the crisis of loneliness in our society with the power of the human-animal bond.”

Loneliness currently affects three in five Americans and 9 million people in the United Kingdom. Loneliness can be as deadly as smoking 15 cigarettes per day, making it a serious threat to public health. Mars Petcare and HABRI surveyed 2,000 people in the United States, finding that 85 percent of respondents believe interaction with companion animals can help reduce loneliness.

“We have a responsibility to take the scientific exploration further when evidence to date shows us that pets can be part of addressing such a significant societal issue,” commented Rena Crumplen, Global Vice President of Research and Development, Mars Petcare. “It’s important that we undertake rigorous studies to understand how companion animals may provide a benefit for those suffering from conditions associated with social isolation and loneliness.”

The new report, Addressing the Social Isolation and Loneliness Epidemic with the Power of Companion Animals, brings forward the recommendations from the Summit on Social Isolation and Companion Animals, along with the continued work of a broad consortium of human health advocates, mental health practitioners, veterinarians and human-animal interaction researchers. The report outlines the following three-pronged approach to facilitate the role of HAI and pet ownership in addressing social isolation and loneliness:

1. Advance High-Quality Research: Advance human-animal interaction (HAI) research to glean a better understanding for whom and under what circumstances interactions with companion animals may be effective for alleviating social isolation and loneliness.

2. Help Address Barriers and Provide Solutions: Identify ways to remove barriers to access for pet ownership and human-animal interaction for those who may face hurdles and stand to benefit most – including older adults and people with mental health challenges.

3. Share and Support the Proliferation of Best Practices: Support and help advance best practices in HAI and for companion animal ownership that help prevent, reduce and mitigate social isolation and loneliness. Ensure animal-assisted interventions in approved settings – including hospitals, nursing homes and within our communities – are grounded in science, meet high standards of animal welfare, and have the broadest societal impact.

Organizations that have contributed to the report, through participation in the Summit and the ongoing consortium working groups, include:


  • Alliance for Aging Research
  • American Pet Products Association
  • Animal Policy Group
  • Association of American Veterinary Medical Colleges
  • Association of Child Life Professionals
  • Anxiety and Depression Association of America
  • American Veterinary Medical Association
  • Baltimore VA Medical Center
  • Banfield Pet Hospital
  • California State Polytechnic University
  • Canine Companions for Independence
  • Cummings School of Veterinary Medicine at Tufts University
  • Depression and Bipolar Support Alliance, Chicago Headquarters
  • Eunice Kennedy Shriver National Institute of Child Health & Human Development
  • Florida State University
  • Found Animals Foundation
  • The Gerontological Society of America
  • Guide Dogs for the Blind
  • Humane Rescue Alliance
  • International Council on Active Aging
  • Mental Health America
  • National Academies of Sciences, Engineering and Medicine
  • National Association for Home Care & Hospice
  • National Council on Aging
  • North American Veterinary Community
  • Petco Foundation
  • Pet Industry Joint Advisory Council
  • Pet Partners
  • Purdue University College of Veterinary Medicine
  • Sick Cells
  • University of Maryland, Baltimore
  • University of Pennsylvania, School of Veterinary Medicine
  • University of Tennessee Institute of Agriculture, College of Veterinary Medicine
  • Village to Village Network
  • Virginia Commonwealth University
  • Whistle

Click here to access: Addressing the Social Isolation and Loneliness Epidemic with the Power of Companion Animals. To learn more about research into the benefits of pets on loneliness, please visit http://www.waltham.com and http://www.habri.org. To learn more about the benefits of pets and how you can take action in your community so that more people and pets can live healthy lives together, visit http://www.BetterCitiesforPets.com.

About the Human Animal Bond Research Institute (HABRI)

The Human Animal Bond Research Institute (HABRI) is a not-for-profit organization that maintains the world’s largest online library of human-animal bond research and information; funds innovative research projects to scientifically document the health benefits of companion animals; and informs the public about human-animal bond research and the beneficial role of companion animals in society. For more information about HABRI, please visit http://www.habri.org.

About Mars Petcare

Part of Mars, Incorporated, a family-owned business with more than a century of history making diverse products and offering services for people and the pets people love, the 85,000 Associates in Mars Petcare are dedicated to one purpose: A BETTER WORLD FOR PETS. With 75 years of experience, our portfolio of almost 50 brands serves the health and nutrition needs of the world’s pets – including brands PEDIGREE®, WHISKAS®, ROYAL CANIN®, NUTRO™, GREENIES™, SHEBA®, CESAR®, IAMS™ and EUKANUBA™ as well as The WALTHAM Petcare Science Institute which has advanced research in the nutrition and health of pets for over 50 years. Mars Petcare is also a leading veterinary health provider through a network of over 2,000 pet hospitals including BANFIELD™, BLUEPEARL™, PET PARTNERS™, VCA™, Linnaeus and AniCura. We’re also active in innovation and technology for pets, with WISDOM PANEL™ genetic health screening and DNA testing for dogs, the WHISTLE™ GPS dog tracker, and LEAP VENTURE STUDIO accelerator and COMPANION FUND™ programs that drive innovation and disruption in the pet care industry. As a family business and guided by our principles, we are privileged with the flexibility to fight for what we believe in – and we choose to fight for: A BETTER WORLD FOR PETS.

i. Cigna Ipsos USA loneliness survey. January 2020. Available here: https://www.cigna.com/newsroom/news-releases/2020/cigna-takes-action-to-combat-the-rise-of-loneliness-and-improve-mental-wellness-in-america

ii. British Red Cross and Co-op Trapped in a bubble: An Investigation into Triggers for Loneliness in the UK. Conducted by Kantar Public. December 2016. Available here: https://www.redcross.org.uk/about-us/what-we-do/action-on-loneliness

iii. Testimony before the US Senate Aging Committee, Julianne Holt-Lunstad, Ph.D., 2017; https://www.aging.senate.gov/imo/media/doc/SCA_Holt_04_27_17.pdf.

iv. HABRI and Mars Petcare Loneliness and Social Isolation Study. Conducted by Edelman Intelligence. December 2018.

Share article on social media or email:

South Bay SUV Shoppers Can Soon Get the 2020 Volkswagen Atlas Cross Sport at Pacific Volkswagen


Pacific Volkswagen will soon offer the 2020 Volkswagen Atlas Cross Sport, which is a sportier and smaller version of the Volkswagen Atlas.

The Volkswagen Atlas has been an incredible success since its debut two years ago — and now Volkswagen is expanding the Atlas lineup with the 2020 Volkswagen Atlas Cross Sport. The Atlas Cross Sport, which is a sportier and smaller version of the Atlas, greatly impresses, with its eye-catching design, robust engine options, a roomy and well-equipped interior, advanced driving assistance technologies and off-road capabilities. SUV shoppers from the South Bay of Los Angeles can soon get the 2020 Atlas Cross Sport at Pacific Volkswagen, with it arriving at the dealership in Spring 2020.

The 2020 Atlas Cross Sport delivers excellent performance with its two powerful engine options. The 2.0-liter turbocharged four-cylinder engine produces 235 horsepower and 258 pound-feet of torque, while the 3.6-liter V6 engine cranks out 276 horsepower and 266 pound-feet of torque. All Atlas Cross Sport models come equipped with a smooth-shifting eight-speed transmission, while the available 4Motion all-wheel drive system provides superb traction when heading off the beaten path and when driving in adverse weather conditions. When equipped with the V6 engine and the V6 Towing Package, the Atlas Cross Sport can tow up to 5,000 pounds.

Volkswagen infused the Atlas Cross Sport with a very high level of safety, especially with its plethora of safety-enhancing driving assistance features. This includes Blind Spot Monitoring, Forward Collision Warning with Autonomous Braking, Adaptive Cruise Control, Park Distance Control, Rear Traffic Alert, Dynamic Road Sign Display and Traffic Jam Assist.

The Atlas Cross Sport has an eye-catching look, with its wide stance, a three-bar chrome grille and a sculpted profile. Despite a length that is 2.8 inches shorter than the standard Atlas model, the Atlas Cross Sport offers a surprising amount of space for passengers, with a total passenger volume of 111.8 cubic-feet and a generous amount of legroom and headroom. The Atlas Cross Sport also offers plenty of cargo space, with a maximum cargo capacity of 77.8 cubic-feet.

Additional information about the 2020 Atlas Cross Sport and other models at Pacific Volkswagen can be found by visiting the dealership’s website at http://www.pacificvolkswagen.com, calling (424) 264-0813 or visiting in person at 14900 Hindry Avenue in Hawthorne.

Share article on social media or email:

Isagenix Poised for Growth as It Prepares for Its 18th Anniversary


News Image

With more than $7 billion in cumulative global sales, as well as more than 400,000 customers worldwide, Isagenix is poised for growth with new independent distributors and customers experiencing our amazing offerings every day. – Travis Ogden, Isagenix CEO

Isagenix International, a legacy global health and wellness company, continues to demonstrate its commitment to healthy change as it prepares for its 18th birthday in March. With a new chief visionary officer focused on positive impact for both customers and the planet for years to come, Isagenix is leading the way in sustainability, customer and independent distributor experience, and product offerings.

“With more than $7 billion in cumulative global sales, as well as more than 400,000 customers worldwide, Isagenix is poised for growth with new independent distributors and customers experiencing our amazing offerings every day,” said Travis Ogden, Isagenix chief executive officer. “We recognize the critical need to continue to innovate and invest in our business. By taking steps like eliminating our customer membership fee and regularly launching new products, we are prepared for a bright future.”

Erik Coover, son of Isagenix Co-Founders Jim and Kathy Coover, was promoted earlier this year to chief visionary officer with the main focus of driving the company’s strategic vision, originally established by his parents, to impact world health and free people from physical and financial pain, and in the process, create the most trusted and respected health and wellness company in the world. In addition, Erik leads the fastest-growing Isagenix demographic — millennials — and spearheads the company’s aggressive sustainability initiatives with a goal of zero waste packaging by 2028. One project contributing to the 2028 goal is transitioning all bottles and canisters to 100% post-consumer recycled (PCR) plastic by 2023. To date, more than 6 million canisters have been packaged in 100% PCR plastic, which is made using less energy and fossil fuels than recyclable virgin plastic. Switching the canisters to PCR plastic costs Isagenix more than $400,000 each year, a cost the company is absorbing and not passing on to customers.

Travis Ogden continued, “Erik is a perfect fit for this position because of his visionary leadership. He has worked his way up at Isagenix over the past decade, so he intimately understands the needs of our customers and our independent distributors. Alongside our incredible executive leadership team, Erik will help Isagenix stay steadfast in our approach as we focus on significant developments in technology and product innovation in 2020.”

Last month, Isagenix launched new wellness products to support customers working toward their health and wellness goals. Peanut Butter Bliss Snack Bites is a new 100-calorie snack that’s designed to not only taste good but also to help satisfy hunger between meals. BĒA™ Sparkling Energy Drink expanded its lineup with a Citrus Sunrise flavor. BĒA’s original Berry Bellini flavor debuted when the product launched in fall of 2019. BĒA both energizes and nourishes the body with 125 milligrams of naturally sourced caffeine from green tea as well as raw nutrients and vitamins sourced from fruits and vegetables.

In addition to debuting new product offerings in January, Isagenix also announced simplified customer membership benefits including the removal of the annual membership fee for customers and a new bonus opportunity for independent distributors. Now, customers receive a 25% discount on products when ordering without paying a membership fee, and independent distributors who meet all qualifying criteria can earn a bonus of up to $10,000 over 12 months.*

To learn more about Isagenix, visit the Newsroom, like the company on Facebook, and follow it on Twitter and Instagram.

*The ability to earn income under the Isagenix Compensation Plan depends on many factors including an individual Isagenix independent distributor’s business, social, and sales skills; personal ambition and activity; availability of time and financial resources; and access to a large network of family, friends, and business contacts. Isagenix cannot and does not guarantee any particular level of earnings. Even independent distributors who dedicate a significant amount of time, effort, and personal funds may not achieve a meaningful level of success. For average earnings, refer to IsagenixEarnings.com.

About Isagenix International

Established in 2002, Isagenix provides systems for weight loss, performance, vitality and well-being, personal care and beauty, and financial wellness. With more than 400,000 customers worldwide and more than 100 products, packs, and systems globally, the company is committed to supporting healthy change in its customers’ and independent distributors’ lives. Isagenix shares its products and solutions through a network of independent distributors in 14 markets: the United States, Canada, Puerto Rico, Hong Kong, Australia, New Zealand, Taiwan, Mexico, the United Kingdom, Ireland, the Netherlands, Belgium, Spain, and South Korea. Isagenix is a privately owned company with headquarters in Gilbert, Arizona. For more information, visit Isagenix.com.

Share article on social media or email:



Health Canada-DEA Approves MMJ International Holdings To Ship THC


MMJ International Holdings- DEA Meeting

“We are pleased with Health Canada’s approval, and the DEA ‘s cooperation to facilitate our company mission to service the unmet needs of patients suffering from these chronic diseases.” Duane Boise CEO

MMJ International Holdings, the premier medical cannabis research company, announced that it has received approval from Health Canada to ship THC and CBD from Canada.

MMJ International Holdings is developing an oral drug product from natural whole plant extract derivatives from the marijuana plant containing THC and CBD. MMJ will be utilizing its new product for an FDA approved treatment for multiple sclerosis (MS) and Huntington’s disease (HD). It also received the US Drug Enforcement Agency’s approval to ship the compounds for its clinical trials.

“As MMJ International Holdings continues to advance to its clinical trials, a specialty pharmaceutical solutions company will be supporting MMJ with the FDA, DEA required development API and specialized liquid encapsulation solutions,” said Elio Mariani, PhD, EVP of research & development. “Patients will benefit from cGMP-quality therapies in an accessible and efficient format.”

Most recently the FDA awarded MMJ International Holdings ″Orphan Drug Designation″ for its THC and CBD proprietary drug formulation which will be used for the treatment of Huntington’s Disease. The drugs, MMJ-001 and MMJ-002 are two of MMJ’s lead drugs that the company is confident will bring much-needed relief to patients suffering from the debilitating effects of Multiple Sclerosis and Huntington’s Disease.

“We firmly believe that our MMJ natural whole plant-derived molecules with a unique combination of pharmacological properties will be FDA approved as a safe and effective prescription drug that can be of great benefit in treating patients with MS and HD diseases,” said Duane Boise, CEO of MMJ International Holdings. “We are pleased with Health Canada’s approval, and the DEA ‘s cooperation to facilitate our company mission to service the unmet needs of patients suffering from these chronic diseases.”

Tim Moynahan the company chairman stated that, “Patients in the MMJ International holdings clinical trials will receive gelatin capsules containing THC and CBD daily. MMJ International Holdings has several academic institutions preparing to study cannabis in Multiple Sclerosis and Huntington’s disease.” MMJ clinical trials will provide the necessary data to prove that cannabis can treat essential tremors, a neurological disorder that causes involuntary shaking. Tim Moynahan further stated that, “Ultimately, there’s so much interest in THC and CBD as a treatment modality, so MMJ will be providing the clinical research data necessary to prove patient dosing, safety, and efficacy.”

EFFICACY THROUGH CLINICAL TRIALS

With the MMJ’s proper formulation of THC and cannabinoids Health Canada and the DEA has afforded MMJ the opportunity to supply its FDA approved clinical trials. MMJ International Holdings FDA studies will begin shortly in Multiple Sclerosis and Huntington’s disease. MMJ’s is in collaboration with a major US Pharma Solutions Company that develops and produces drug delivery systems. The Pharma Solutions Company offers manufacturing, packaging, storage, and inventory management services for FDA approved drugs, biologics, and consumer health products.

STATE TO STATE MARIJUANA BUSINESSES AT RISK

Recently, President Tump’s budget proposal would remove protections for medical marijuana states and block Washington, D.C. from legalizing sales. The reason why the Federal Government is opposed to the state to state federally illegal marijuana products is that “There is a significant gap in our understanding of their impact on health,” Nora Volkow, Director of NIDA said.

Furthermore, “The recent outbreaks of e-cigarette or vaping product use associated lung injury (EVALI), which has been linked to informally-sourced THC-containing vape products, underscores the critical importance of facilitating researcher access to different product sources.”

The budget proposal will allocate about $4 million to an initiative designed to “better regulate THC and cannabis-derived substances in FDA-regulated products. It will also “support regulatory activities, including developing policies and continue to perform its existing regulatory responsibilities including review of drug product applications, inspections, enforcement, and targeted research.” The FDA is committed to protecting the public health and improving regulatory pathways for the lawful marketing of THC and cannabis-derived products within the agency’s jurisdiction. “In many cases, product developers make unproven claims to treat serious or life-threatening diseases, and patients may be misled to forgo otherwise effective, available therapy and opt instead for a product that has no proven value or may cause them serious harm.”

MMJ International Holdings continues its process of scientific drug development and discovery by FDA protocol development processes, intellectual property portfolio, and DEA regulatory manufacturing guidelines to protect the public health interest.

Share article on social media or email:

Banyan Security to Showcase and Lead Industry Discussions on Zero Trust Remote Access at RSA Conference 2020


Banyan Security

Banyan Security

“Zero Trust will be a big topic at this year’s conference as businesses of all sizes begin to understand the risks they take using traditional methods to secure remote access,” said Jayanth Gummaraju, co-founder and CEO, Banyan Security.

Banyan Security, a leading provider of a human-centric secure remote access solution based on Zero Trust security principles and designed from the ground up for today’s hybrid and multi-cloud environments, today announced it will showcase its Zero Trust Remote Access platform at RSA Conference 2020. Additionally, company Co-Founder and Chief Operating Officer Tarun Desikan will speak at the conference on the challenges of securing the remote workforce. RSA Conference 2020 takes place February 24–28, 2020 in San Francisco, California.

“Zero Trust will be a big topic at this year’s conference as businesses of all sizes begin to understand the risks they take using traditional methods to secure remote access,” said Jayanth Gummaraju, co-founder and CEO, Banyan Security. “We look forward to showcasing our platform at RSA and offering businesses a better, safer way to secure their mobile workforces and hybrid cloud environments.”

Banyan Security has set a new standard in Zero Trust with the industry’s most human-centric Zero Trust Remote Access solution. Banyan empowers users with comprehensive TrustScoring, that integrates with existing enterprise investments in identity and security tools. Banyan replaces legacy VPN with Zero Trust Access that provides least privilege access to on-premises and cloud environments, and allows for a BYOD-friendly workplace, allowing customers to secure their modern, perimeter-free enterprise.

“BlueVoyant clients demand a world-class cybersecurity team with industry-standard security controls. As a result, we’ve implemented a zero-trust, whitelist-only approach to protecting information,” said Sadiq Khan, CISO, BlueVoyant. “Banyan’s extensible security platform is unparalleled in its ability to enable us to accomplish all the goals of implementing a Zero Trust program while leveraging our existing technology suite.”

Banyan Security RSA Showcase Details

WHAT – Banyan Security to Showcase Zero Trust Remote Access Platform at RSA Conference 2020.

WHERE – Booth 15, Early Stage Expo, Moscone Center, San Francisco

WHEN – February 24–28, 2020

Banyan Security Featured Speaker Session

WHAT – “The 3rd Party Dilemma – Securing Remote Access Without a VPN”

WHO –Tarun Desikan, Co-Founder and Chief Operating Officer, Banyan Security

WHERE – Early Stage Expo

WHEN – February 27, 2020, 1:00–1:20p.m.

SESSION DETAILS – Each day, millions of remote workers log in from destinations across the globe. As employees sign in from different devices and locations, this presents a major challenge for businesses trying to ensure secure remote access. Learn how to solve the challenge of securing the remote workforce, the trouble with VPN’s, and how Banyan’s solution is providing Zero Trust Remote Access for a perimeter-free enterprise.

For more information, visit http://www.banyansecurity.io.

About Banyan Security

Banyan Security’s next-generation Zero Trust Remote Access platform provides seamless remote access to corporate resources hosted in hybrid and multi-cloud environments. Banyan enhances security by reducing your attack surface, eliminating lateral movement, and preventing unauthorized access. Utilizing innovative TrustScoring powered by machine learning, Banyan ensures both users and devices are authenticated and authorized before granting granular least privilege access to sensitive corporate applications and servers. Banyan’s highly scalable platform is currently used by enterprises across verticals including healthcare, manufacturing, and technology. To learn more, visit http://www.banyansecurity.io.

Share article on social media or email:

Dr. Langsdon Featured As Top Rhinoplasty Surgeon


Dr. Phillip R. Langsdon, a board-certified facial plastic surgeon and immediate past president of the American Academy of Facial Plastic and Reconstructive Surgery (AAFPRS), was recently recognized for his expertise in rhinoplasty in an AAFPRS video highlighting the 2020 Advances In Rhinoplasty Symposium scheduled for Miami, Florida, this May. The video is disseminated to facial plastic surgeons and plastic surgeons around the world.

AAFPRS is a medical society focused on plastic and reconstructive surgery. While Dr. Langsdon is already highly recognized as a facial plastic surgeon, professor, physician, and author, he is also among the leading rhinoplasty experts in the world.

With over 25 years of experience performing rhinoplasty surgery, Dr. Langsdon has established innovative methods that aim to address the specific needs of each patient. His exceptional skills and experience ensure that his rhinoplasties are precise, minimally invasive, and give the patient a balanced and proportional nose.

“I take pride in my ability to identify a patient’s aesthetic needs,” Dr. Langsdon said. “I recognize that each nose is different and that all patients are going to have different ideas of what the outcome should be. Patients can rest assured that the results of the procedure will be natural and balanced.”

While rhinoplasties are one of The Langsdon Clinic’s specialties, Dr. Langsdon and his team are also well-known for specializing in facial cosmetic surgery, including facelifts, otoplasties, eyelid surgeries, and hair restorations. The Langsdon Clinic, established in 1986 in Germantown, Tenn., is one of the leading facial plastic surgery institutions in the United States. Patients in the Memphis and Mid-South areas do not have to fly to Beverly Hills or New York City to find the very best facial plastic surgery.

Apart from his expertise in rhinoplasty surgeries, Dr. Langsdon has continued to earn accolades as one of the top facial plastic surgeons in the country. He has been voted as one of “America’s Top Plastic Surgeons” and “America’s Best Doctors” time and time again. The Memphis daily newspaper, The Commercial Appeal, honored The Langsdon Clinic as the best cosmetic surgery practice in the Memphis area for many consecutive years. Dr. Langsdon is an outstanding facial plastic surgeon whose skills in rhinoplasty are among the best in the world.

If you are interested in learning more about The Langsdon Clinic, please visit: https://www.drlangsdon.com.

To see Dr. Langsdon being featured in the AAFPRS Advances in Rhinoplasty video, please paste the following link into your browser: https://youtu.be/Izfk6A3lRRk.

Share article on social media or email:

Bellus3D Announces Dental Pro 2.0


News Image

We believe that smiles begin with the face in mind. Dental Pro 2.0 allows clinicians to generate fast, easy and affordable 3D face scans, integrate those scans with intraoral and CBCT scans and then share them with dental labs to form a complete picture of the patient.

Bellus3D, Inc. a Silicon Valley startup formed by leading computer vision experts, is announcing Bellus3D Dental Pro 2.0, a major new release of its leading iOS 3D face scanning app for the dental market. The new release extends the capturing to include the new Bellus3D ARC multi-camera scanning system, and adds an online workflow via Bellus3D Face Cloud that allows dental specialists and dental labs to collaborate and accelerate high-value case acceptance.

In addition to supporting Apple iPad Pro and Apple iPhone X, Bellus3D Dental Pro 2.0 adds the support of Bellus 3D ARC systems. Bellus3D ARC is a revolutionary multi-camera 3D face scanning solution that captures professional grade, full 3D face scans in seconds. Bellus3D ARC can be configured from 1 to 7 smart depth-sensing WiFI cameras and works with a Windows 10 PC. ARC provides near instant capture with no moving parts and requires no movement by the subject.

Bellus3D Face Cloud provides a platform for viewing and manipulation of face scans within a browser in both desktop or mobile environments. Face Cloud accepts 3D face models created from both Bellus3D iOS app or the ARC system. The workflow allows clinicians to scan the patient’s face using ARC or a supported iOS device and then share that scan with the dental lab remotely. Integration with leading intraoral scanner providers, such as 3Shape and Dental Wings, allows the patient’s face to be aligned with the digital scan of the teeth and then integrated into the chairside and dental lab planning software to ensure proper 3D registration of the face scan to the dental surface scans for diagnostic, surgical and restorative smile design planning.

Dental Pro 2.0 features include:

  • Model Sharing–allows clinicians and labs to share face scans and collaborate on treatment plans
  • Workspace Sharing–dental labs can share designs with clinicians for case acceptance and approval
  • Visual Smile Aligner(™) tool to precisely align 3D face scan with dental .ply or .stl scans
  • Access to teeth library where labs and clinicians can select from dozens of sets of teeth for use in smile design
  • Lip Line Editor–ensures you can see the teeth clearly in the face
  • Aesthetic Guides–allows clinician to identify Midline, Interpupillary, Camper and Occlusal planes

“Dental Pro 2.0 allows clinicians to generate fast, easy and affordable 3D face scans, integrate those scans with intraoral and CBCT scans and then share them with dental labs to form a complete picture of the patient. We believe that smiles begin with the face in mind and this is the latest step in our goal of enabling product companies to bring a high level of personalization to their products,” said Eric Chen, CEO of Bellus3D, Inc.

The company is demonstrating Dental Pro 2.0 and providing free 3D face scans to interested attendees at Lab Day 2020 booth #A-21 in Chicago this week.

Bellus3D Dental Pro 2.0 is available now for direct download on the Apple App Store. All Dental Pro accounts include a 2-week free trial to eliminate any risk associated with trying the application and after the free trial, a monthly subscription is only $80 per month. Annual licenses can be obtained through Whip Mix or other authorized Bellus3D resellers at discounted prices.

About Bellus3D, Inc.

Bellus3D (https://www.bellus3d.com) is the innovative leader in high-resolution 3D face scanning. Our goal is to enable personalized products using the face by providing fast, easy and affordable 3D face scanning to companies and individuals who are creating products for the face. We are working with companies in key vertical markets including dental, eyewear, medical, cosmetic and 3D Printing to facilitate their goal of delivering highly personalized products to their customers.

More information about Bellus3D products: https://www.bellus3d.com

Bellus3D Press Contact: Nick Blozan, nblozan(at)Bellus3D.com, Phone: (408) 502-5012

Bellus3D Reseller Contact: Mark Smolinski, msmolinski(at)Bellus3D.com, Phone: (408) 761-5786

Bellus3D, Bellus3D Dental Pro, the Bellus3D logo, and Bellus3D ARC are registered trademarks of Bellus3D, Inc.

Share article on social media or email: